Basel Medical Group Ltd
BMGL
$4.45
$0.040.91%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 55.00% | 53.14% | -- | -34.60% | |
| Total Receivables | -6.79% | -7.91% | -- | -- | |
| Inventory | -24.03% | -24.89% | -- | -- | |
| Prepaid Expenses | -22.96% | -24.00% | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 9.29% | 7.97% | -- | -- | |
|
|
|||||
| Total Current Assets | 9.29% | 7.97% | -- | -- | |
| Net Property, Plant & Equipment | -89.99% | -90.12% | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 178.43% | 175.85% | -- | -- | |
| Total Assets | 5.86% | 4.58% | -- | -- | |
|
|
|||||
| Total Accounts Payable | -43.46% | -44.14% | -- | -- | |
| Total Accrued Expenses | 375.85% | 369.97% | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -28.70% | -29.56% | -- | -- | |
| Total Finance Division Other Current Liabilities | -18.69% | -19.66% | -- | -- | |
| Total Other Current Liabilities | -18.69% | -19.66% | -- | -- | |
| Total Current Liabilities | 10.56% | 9.23% | -- | -- | |
|
|
|||||
| Total Current Liabilities | 10.56% | 9.23% | -- | -- | |
| Long-Term Debt | -53.44% | -54.00% | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | -11.72% | -12.78% | -- | -- | |
|
|
|||||
| Common Stock & APIC | -- | -- | -- | -- | |
| Retained Earnings | 37.53% | 35.88% | -- | -- | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 37.53% | 35.88% | -- | 93.28% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 37.53% | 35.88% | -- | 93.28% | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 37.53% | 35.88% | -- | 93.28% | |
|
|
|||||